Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ALG-000111
/
Aligos Therap
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||||||||
ALG-000286
/
Aligos Therap
,
ALG-000111
/
Aligos Therap
[VIRTUAL] Capsid assembly modulator ALG-000111 and its prodrug ALG-000286 display excellent in vitro and in vivo antiviral activity
(Poster area) - Apr 9, 2021 - Abstract #EASLILC2021EASL_ILC_1145;
With sub-nanomolar activity and deep knockdown of HBV DNA in cell-based assays and the AAV-HBV mouse model, ALG- 000286 is a promising Class II CAM candidate for further development.